Clobazam 62135-0527-41
- Manufacturer
- Chartwell Rx, Llc
- Dosage Form
- Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIV
- Marketing Start
- April 24, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA213110
Active Ingredients
| Ingredient | Strength |
|---|---|
| Clobazam | 2.5 mg/mL |
Drug Class
Benzodiazepine [EPC]Benzodiazepine [EPC]Benzodiazepines [CS]
Selected Package
62135-0527-41Selected120 mL in 1 BOTTLE (62135-527-41)